Home » Newsletters » BioWorld

BioWorld

March 8, 1993

View Archived Issues

TOOTHPASTE TO TREAT PERIODONTAL DISEASE

PROCYTE UNDERWRITERS EXERCISE OVERALLOTMENT

PRP PATENT FOR PLATELET DERIVATIVE

EUROPEAN PATENT DISCLOSURES

ORAVAX COMPLETES OVERSUBSCRIBED FINANCING

TRANSPLANT REJECTION DRUG SAFE IN TRIAL

CYTEL UNDERWRITERS EXERCISE OPTION

INCYTE EXTENDS RESEARCH PACT

ID2 ALLIES WITH OHIO UNIVERSITIES

RELIEF MAY BE NEAR FOR ALLERGY SUFFERERS

AGRISTAR GETS PATENT FOR EDIBLE VACCINE

BIOSPECIFICS GRANTED PATENT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...